No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Female
-
Humans
-
Imatinib Mesylate / adverse effects*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Middle Aged
-
Pyoderma Gangrenosum / chemically induced*
-
Pyoderma Gangrenosum / pathology*
Substances
-
Antineoplastic Agents
-
Imatinib Mesylate